DEF 14A

Company

Traws Pharma, Inc.

Filed

May 25, 2022

Period of Report

July 21, 2022

Accession Number

0001104659-22-064708

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →